As such, allopurinol could improve fatty liver through the modulation of PPARα signaling, and its efficacy serves as evidence that uric acid is directly involved in the development of NAFLD. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.